News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Vir Biotechnology rallied after a Phase-3 trial win, pushing market capitalization to about $2.34 billion.
  • Valuation appears tight versus near-term binary catalysts; cautious long recommended with limited position size and a hard stop.
  • Celestica trades near $223 after a steep fall from its 52-week peak while reporting $545 million in free cash flow.
  • Recommend a tactical 45-day short on Celestica driven by sagging AI revenue expectations.
  • Event-driven stock trades dominated the hour, with catalyst-driven biotech moves and targeted shorts in AI-supply names.

Latest Articles

Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform

Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform

Verisk Analytics has introduced Fraud Discovery, an integrated fraud prevention platform combining intelligence, analytics, network analysis, digital forensics, and case management. The platform aims to help insurers detect and combat increasingly sophisticated and organized fraud schemes by uncovering hidden relationships and prioritizing investig…

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Upstream Bio announced positive results from the Phase 2 VALIANT trial of verekitug, a novel TSLP receptor antagonist, demonstrating a 56% reduction in annualized asthma exacerbation rate compared to placebo in severe asthma patients. Verekitug also improved lung function and inflammatory biomarkers with favorable safety. The company plans to start…

Oil climbs as Iran warns Gulf energy infrastructure could be targeted

Oil climbs as Iran warns Gulf energy infrastructure could be targeted

Oil prices continued to rise on Tuesday, with Brent crude holding above $97 a barrel and U.S. WTI advancing strongly, after Iranian officials warned that oil and gas infrastructure in the Gulf could be subject to retaliation. Statements from Iranian leaders about a potential maritime exclusion zone and alternative shipping corridors have intensifie…

Magnite Launches First Agentic Campaign in EMEA With Amnet France

Magnite Launches First Agentic Campaign in EMEA With Amnet France

Magnite (NASDAQ: MGNI) announced the launch of its first agentic campaign in EMEA through collaboration with Amnet France, utilizing AI-powered buyer agents to automate and optimize premium connected TV (CTV) advertising campaigns. The campaign for a leading automotive client resulted in a 70% reduction in setup time and a 95% view-through rate, sh…

ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV

ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV

ASML and TSMC have launched a collaborative industry initiative to transition the semiconductor industry to larger 12-inch photomasks for High Numerical Aperture Extreme Ultraviolet (High NA EUV) lithography. This initiative aims to establish a pilot line by 2031 and enable advanced node production by 2033, improving fab productivity, lowering chip…

Mercury Systems: Edge Compute Momentum Meets an Oversold Setup

Mercury Systems: Edge Compute Momentum Meets an Oversold Setup

Mercury Systems ($82.41) is a pure-play defense edge-computing supplier seeing accelerating bookings and multi-year production demand for secure servers and solid-state data recorders. Recent contract wins and a meaningful production order support a mid-term swing long. Technicals show oversold conditions (RSI ~32) but momentum is negative; pair th…

Lumentum: Speed Is Everything - A Mid-Term Trade on AI Optics Momentum

Lumentum: Speed Is Everything - A Mid-Term Trade on AI Optics Momentum

Lumentum (LITE) is uniquely positioned to monetize the AI datacenter optics wave with near-packaged optics and kilowatt-class lasers. Revenue is ripping higher, margins are expanding and free cash flow is positive - but valuation is steep. This is a disciplined mid-term (45 trading days) long trade: enter near current levels, limit downside with a …

Why Brent Hasn’t Cleared $100 Despite Mideast Supply Disruptions

Why Brent Hasn’t Cleared $100 Despite Mideast Supply Disruptions

Brent crude has strengthened this month but remained under $100 a barrel even after renewed U.S.-Iran tensions disrupted shipments through the Strait of Hormuz and elsewhere. A combination of meaningful volumes still transiting Hormuz at times, rerouted Gulf exports, rising output from non-OPEC producers, and substantial demand destruction - partic…

Why Zeta Global's AI Momentum Still Justifies a Swing Trade

Why Zeta Global's AI Momentum Still Justifies a Swing Trade

Zeta Global reported another strong quarter with $442.8M revenue (+43.5% YoY) and raised full-year guidance to roughly $1.82B. The business is scaling rapidly, AI adoption is accelerating customer expansion, and free cash flow now exceeds $214M. For traders willing to accept some valuation multiple compression risk, a disciplined swing trade captur…

Yen Strengthens as Markets Push Back BOJ Timing and Price in a September Hike

Yen Strengthens as Markets Push Back BOJ Timing and Price in a September Hike

The Japanese yen extended its recent advance on Tuesday, hitting a seven-month high against the dollar as traders intensified expectations that the Bank of Japan will raise interest rates at its Sept. 17-18 policy meeting. Upward revisions to second-quarter GDP and a notable rise in real wages added momentum to the currency's move, while Tokyo reit…